Med. praxi. 2023;20(5):269-273 | DOI: 10.36290/med.2023.041

Sudden cardiac death and its prevention

MUDr. Alice Krebsová, Ph.D.1, Mgr. Bc. Eva Kutílková, Ph.D.1, prof. MUDr. Milan Macek, DrSc.2
1 IKEM, Klinika kardiologie, Centrum dědičných kardiovaskulárních onemocnění, Praha, ERN GUARD Heart
2 Ústav biologie a lékařské genetiky 2. LF UK a FN Motol, Praha, ERN ITHACA

A significant percentage of sudden cardiac death (SCD) in individuals under 50 years of age is caused by hereditary cardiovascular disease. Identifying these cases, performing post-mortem genetic testing and cardiac screening of direct relatives is the first step to primary prevention of cardiac death in survivors and requires multidisciplinary and multicentre collaboration.

Hereditary cardiovascular diseases include diseases of the heart muscle (cardiomyopathy), electrical diseases (arrhythmogenic syndromes) and hereditary diseases of the aorta and large vessels, where patients are at risk of premature cardiac arrest or acute dissection of large vessels.

Cardiogenetic examination is a complex interdisciplinary examination in which cardiologists, molecular and clinical geneticists, pathologists and psychologists participate.

General practitioners are often the first to be contacted by the bereaved and their recommendation is often crucial to the next fate of the relatives.

Communication between individual experts and teams of individual centres is absolutely essential to ensure care for patients with an often very rare form of hereditary disease with a risk of sudden cardiac death.

Keywords: hereditary cardiovascular diseases, genetic analysis, cascade family screening.

Received: September 1, 2023; Revised: October 10, 2023; Accepted: October 11, 2023; Published: December 19, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krebsová A, Kutílková E, Macek M. Sudden cardiac death and its prevention. Med. praxi. 2023;20(5):269-273. doi: 10.36290/med.2023.041.
Download citation

References

  1. Stiles MK, Wilde AAM, Abrams DJ, et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm. 2021;18:e1-e50. Go to original source... Go to PubMed...
  2. Wilde AAM, Semsarian C, Márquez MF, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases. Heart Rhythm. 2022;19:e1-e60. Go to original source... Go to PubMed...
  3. Verhagen JMA, Kempers M, Cozijnsen L, et al. Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first­‑degree relatives. Int J Cardiol. 2018;258:243-248. Go to original source... Go to PubMed...
  4. Zeppenfeld K, Tfelt­‑Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997-4126. Go to original source... Go to PubMed...
  5. Basso C, Aguilera B, Banner J, et al. Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology. Virchows Arch. 2017;471(6):691-705. Go to original source... Go to PubMed...
  6. Charron P, Arad M, Arbustini E, et al. Genetic counselling and testing in cardiomyopathies: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010;31:2715-2728. Go to original source... Go to PubMed...
  7. Votýpka P, Krebsová A, Norambuena­‑Poustková P, et al. Post­‑mortem genetic testing in sudden cardiac death and genetic screening of relatives at risk: lessons learned from a Czech pilot multidisciplinary study. Int J Legal Med. 2023. Go to original source... Go to PubMed...
  8. Rapezzi C, Arbustini E, Caforio AL, et al. Diagnostic work­‑up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:1448-1458. Go to original source... Go to PubMed...
  9. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24. Go to original source... Go to PubMed...
  10. Fellmann F, van El CG, Charron P, et al. European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death. Eur J Hum Genet. 2019;27(12):1763-1773. Go to original source... Go to PubMed...
  11. Wanner C, Arad M, Baron R, et al. European expert consensus statement on therapeutic goals in Fabry disease. Mol Genet Metab. 2018;124(3):189-203. Go to original source... Go to PubMed...
  12. Krebsová A, Pohlová Kučerová Š, Votýpka P, et al. Post mortem vyšetření obětí náhlé srdeční smrti a navazující kaskádový rodinný screening v ČR. Cor et Vasa. 2023;65(1):7-22. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.